MAPELLI, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 393
NA - Nord America 352
AS - Asia 201
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 966
Nazione #
US - Stati Uniti d'America 343
IT - Italia 141
SE - Svezia 128
CN - Cina 111
SG - Singapore 72
RU - Federazione Russa 45
FI - Finlandia 22
DE - Germania 19
AU - Australia 17
CA - Canada 9
FR - Francia 9
IE - Irlanda 8
GB - Regno Unito 7
PL - Polonia 6
HK - Hong Kong 4
ID - Indonesia 3
IN - India 3
JP - Giappone 3
BG - Bulgaria 2
EU - Europa 2
NL - Olanda 2
TW - Taiwan 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
IR - Iran 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 966
Città #
Milan 72
Singapore 51
Ashburn 48
Shanghai 47
New York 40
Boardman 33
Lawrence 26
Moscow 26
Princeton 26
Helsinki 18
Rome 13
Dallas 8
Dublin 8
Washington 7
Canberra 6
London 6
Philadelphia 6
Adelaide 5
Hamilton 5
Los Angeles 5
Lublin 5
Seattle 5
Beijing 4
Hong Kong 4
Lappeenranta 4
Montecchio Maggiore 4
Pesaro 4
Bandung 3
Chiusi 3
Guangzhou 3
Hanover 3
Jiaxing 3
Lissone 3
Pisa 3
St Petersburg 3
Sydney 3
Council Bluffs 2
Engelhard 2
Foshan 2
Hangzhou 2
Mountain View 2
Naples 2
Pescara 2
Razgrad 2
Shenzhen 2
Toronto 2
Vigonza 2
Agrigento 1
Amsterdam 1
Andover 1
Bergamo 1
Black River Falls 1
Boston 1
Bratislava 1
Brussels 1
Buffalo 1
Changsha 1
Columbus 1
Essen 1
Fiorano Modenese 1
Frankfurt am Main 1
Gunzenhausen 1
Hai Duong 1
Haining 1
Hefei 1
Hessisch Oldendorf 1
Houston 1
Jinhua 1
Jiyuan 1
Kolkata 1
Lima 1
Macerata 1
Melbourne 1
Menlo Park 1
Moncton 1
Mumbai 1
Nanjing 1
Neyagawa 1
Pune 1
Romford 1
San Jose 1
Santa Clara 1
Sarno 1
Secaucus 1
Shaoxing 1
Shenyang 1
Stratford 1
Taipei 1
Taizhou 1
Tonekabon 1
Torrile 1
Treviso 1
Warsaw 1
Wuhu 1
Xi'an 1
Zhengzhou 1
Zhenjiang 1
Totale 585
Nome #
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 49
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 43
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 42
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 36
Nuclear medicine in prostate cancer management 33
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 31
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 30
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 30
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 29
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 29
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 28
Clinical implication of multimodality imaging of aortic root intramural hematoma 28
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 28
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 26
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 26
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 26
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 25
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 25
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 24
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 23
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 23
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 22
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 22
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 22
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 22
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 20
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 19
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 19
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 19
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 19
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 19
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 18
PET/MRI and prostate cancer 17
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 17
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 17
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 17
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 15
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 14
Radiomics and artificial intelligence 14
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 13
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL 13
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 12
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer 12
null 11
Association of IgG4-related disease and systemic rheumatic disorders 10
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 10
PET/MRI 9
Imaging in evaluation of response to neo-adjuvant treatment 9
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 7
PET/MRI in gynecological tumors 6
POSITRON EMISSION TOMOGRAPHY/MAGNETIC RESONANCE IMAGING 6
Detection of bone metastases and evaluation of therapy response in prostate cancer patients by radiolabelled choline PET/CT 6
TECNICHE, METODOLOGIE, APPLICAZIONI DIAGNOSTICA PER IMMAGINI 6
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery 1
Totale 1.097
Categoria #
all - tutte 12.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 1 0 0 0 6 1 0
2020/20217 0 0 0 5 0 2 0 0 0 0 0 0
2021/202268 0 6 0 14 9 3 9 9 7 8 1 2
2022/2023310 63 52 21 29 17 27 23 33 4 19 3 19
2023/2024480 40 23 87 53 34 68 16 40 8 12 28 71
2024/2025222 75 29 39 29 50 0 0 0 0 0 0 0
Totale 1.097